ZyVersa Therapeutics highlights data on NLRP3 inflammasome inhibition
ZyVersa highlights newly published data demonstrating that NLRP3 Inhibition attenuates development of AD pathology and neuroinflammation in a ...
Nature22d
Oral STING agonist inhibits tumour growth
Following evaluation of STING activation in human monocytic THP1 cells, extensive structural optimization of a benzothienopyrrolone scaffold led to development of ZSA-51. In THP-1 cells ...